Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Notes Payables (2019 - 2020)

Historic Notes Payables for Arcadia Biosciences (RKDA) over the last 4 years, with Q1 2020 value amounting to $161000.0.

  • Arcadia Biosciences' Notes Payables changed N/A to $161000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $161000.0, marking a year-over-year change of. This contributed to the annual value of $24000.0 for FY2019, which is N/A changed from last year.
  • As of Q1 2020, Arcadia Biosciences' Notes Payables stood at $161000.0.
  • Arcadia Biosciences' Notes Payables' 5-year high stood at $161000.0 during Q1 2020, with a 5-year trough of $24000.0 in Q4 2019.